Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors

Overview of attention for article published in Clinical Pharmacology in Drug Development, June 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 310 followers.

Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors. https://t.co/dUsRusMxIs #longqt #cardiotwitter #epeeps

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.